The clinical and urodynamic results of a 3‐month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis‐related neurogenic bladder dysfunction

Kabay, Şahin; Kabay, Sibel Canbaz; Yücel, Mehmet; Özden, Hilmi; Yılmaz, Zahide; Aras, Özgen; Aras, Bahar

doi:10.1002/nau.20733

Cited by 100 publications

(62 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The precise mechanism of action is unknown, but it has been proposed that PTNS inhibits bladder activity by depolarizing somatic sacral and lumbar afferent fibres. Initial studies of the use of PTNS using either percutaneous or transcutaneous electrodes in MS neurogenic DO have shown it to be an effective, safe and well-tolerated treatment [5,[15][16][17].…”

Section: Introductionmentioning

confidence: 99%

Sacral neuromodulation: an effective treatment for lower urinary tract symptoms in multiple sclerosis

et al. 2015

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Sacral neuromodulation: an effective treatment for lower urinary tract symptoms in multiple sclerosis

et al. 2015

View full text Add to dashboard Cite

show abstract

“…67 Other clinical studies have also demonstrated that peripheral electrical stimulation of the posterior tibial nerve improves clinical and urodynamic outcome and provides long-term efficacy though suppressing neurogenic detrusor overactivity in MS patients. 68,69 However, MS patients with urinary retention due to detrusor underactivity are not suitable for this treatment. 70 The LION (laparoscopic implantation of neuroprosthesis) procedure on the sacral plexus is worth trying if the classical percutaneous technique has been unsuccessful.…”

Section: Neuromodulation Of the Peripheral Nervous Systemmentioning

confidence: 99%

Clinical neurorestorative progress in multiple sclerosis

Geng¹,

Mark²

2015

View full text Add to dashboard Cite

Abstract:With the chronic progress of the disease, the majority of patients with multiple sclerosis will eventually become severely disabled and unable to live independently. Neurorestorative strategies, including cell therapy and neuromodulation, combined with neurorehabilitation, have shown encouraging signs that may benefit multiple sclerosis patients. This review indicates current progress in this area.

show abstract

“…However, the mainstay of available data are from non-neurogenic overactive bladder patients [35,36], but some recent studies also provided data from neurological patients, that is, MS and Parkinson's disease [37][38][39][40][41][42][43][44]. However, randomized controlled trials (RCTs) are lacking for PTNS and TTNS in the neurological population, and there are currently no long-term data or systematic data on HRQoL available.…”

Section: External Neuromodulationmentioning

confidence: 99%

The management of urinary incontinence in the male neurological patient

Mehnert

Kessler

2014

Current Opinion in Urology

View full text Add to dashboard Cite

PURPOSE OF REVIEW: Urinary incontinence in male neurological patients is a very frequent problem but treatment remains challenging. Thus, we summarize and highlight the latest developments in the management of urinary incontinence in this specific patient population. RECENT FINDINGS: Intermittent self-catheterization, antimuscarinics, intradetrusor injections with onabotulinumtoxinA, augmentation cystoplasty, urinary diversion, and artificial urinary sphincter are the cornerstones of the armamentarium for treating neurogenic urinary incontinence. However, with the exception of onabotulinumtoxinA intradetrusor injections, level of evidence is often low and male-specific outcomes are virtually not available. Alternative conservative and/or minimally invasive procedures such as neuromodulation techniques and suburethral suspension devices provide promising data with apparently good safety and tolerability but still insufficient evidence lacking randomized control trials. SUMMARY: Standard options for treatment of urinary incontinence in neurological patients remain largely unchanged. Alternative treatment options, especially of conservative or minimally invasive character, have the potential to further broaden the therapeutic spectrum. While a higher level of evidence is needed to assess the potential of such therapeutic approaches, randomized controlled trials in the male neurological population present a challenge. To truly advance treatment of urinary continence in male neurological patients, well-designed, multicenter studies are warranted. Purpose of review Urinary incontinence in male neurological patients is a very frequent problem but treatment remains challenging. Thus, we summarize and highlight the latest developments in the management of urinary incontinence in this specific patient population. Recent findingsIntermittent self-catheterization, antimuscarinics, intradetrusor injections with onabotulinumtoxinA, augmentation cystoplasty, urinary diversion, and artificial urinary sphincter are the cornerstones of the armamentarium for treating neurogenic urinary incontinence. However, with the exception of onabotulinumtoxinA intradetrusor injections, level of evidence is often low and male-specific outcomes are virtually not available. Alternative conservative and/or minimally invasive procedures such as neuromodulation techniques and suburethral suspension devices provide promising data with apparently good safety and tolerability but still insufficient evidence lacking randomized control trials. SummaryStandard options for treatment of urinary incontinence in neurological patients remain largely unchanged. Alternative treatment options, especially of conservative or minimally invasive character, have the potential to further broaden the therapeutic spectrum. While a higher level of evidence is needed to assess the potential of such therapeutic approaches, randomized controlled trials in the male neurological population present a challenge. To truly advance treatment of urinary continence in mal...

show abstract

The clinical and urodynamic results of a 3‐month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis‐related neurogenic bladder dysfunction

Cited by 100 publications

References 32 publications

Sacral neuromodulation: an effective treatment for lower urinary tract symptoms in multiple sclerosis

Sacral neuromodulation: an effective treatment for lower urinary tract symptoms in multiple sclerosis

Clinical neurorestorative progress in multiple sclerosis

The management of urinary incontinence in the male neurological patient

Contact Info

Product

Resources

About